197 related articles for article (PubMed ID: 7147981)
1. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
2. [Age dependency of platelet half life].
Sinzinger H; Jäger E; Leithner C; Höfer R
Aktuelle Gerontol; 1982 Nov; 12(6):213-6. PubMed ID: 6130714
[TBL] [Abstract][Full Text] [Related]
3. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life.
Strobl-Jäger E; Widhalm K; Sinzinger H
Prostaglandins Leukot Med; 1986 Nov; 25(1):39-47. PubMed ID: 3540998
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
Shattil SJ; Bennett JS; Colman RW; Cooper RA
J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and in vivo distribution of in-111-labelled platelets and platelet function in familial hypercholesterolaemia.
Wessels P; Heyns AD; Esterhuysen AJ; Badenhorst PN; Lötter MG; Pieters H; Kotzè HF
Thromb Haemost; 1987 Oct; 58(3):811-6. PubMed ID: 3433247
[TBL] [Abstract][Full Text] [Related]
8. [Examination of cortisol and insulin levels in serum of patients with primary hyperlipoproteinemia and phenotype IIa and IIb during lovastatin treatment].
Idzior-Waluś B
Przegl Lek; 1992; 49(11):365-8. PubMed ID: 1306568
[TBL] [Abstract][Full Text] [Related]
9. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
Sznajd J; Idzior-Waluś B; Korzus G; Zabiński J; Hebda A; Markiewicz M
Przegl Lek; 1990; 47(10):711-4. PubMed ID: 2089450
[TBL] [Abstract][Full Text] [Related]
10. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
Lopez Rodriguez J; Martorell J
Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
[TBL] [Abstract][Full Text] [Related]
11. Altered platelet deformability in patients with type IIa and type IV hyperlipoproteinemia.
Smith CM; Burris SM; Hunninghake DB; White JG
Am J Hematol; 1988 Apr; 27(4):247-52. PubMed ID: 3354559
[TBL] [Abstract][Full Text] [Related]
12. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.
Muller S; Ziegler O; Donner M; Drouin P; Stoltz JF
Atherosclerosis; 1990 Aug; 83(2-3):231-7. PubMed ID: 2242099
[TBL] [Abstract][Full Text] [Related]
13. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
14. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].
Reuter W
Dtsch Z Verdau Stoffwechselkr; 1979; 39(3):124-9. PubMed ID: 520271
[TBL] [Abstract][Full Text] [Related]
15. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
Lipovetskiĭ BM; Vinogradova TV
Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
[TBL] [Abstract][Full Text] [Related]
16. [Na+, K+-ATPase activity and cholesterol content in erythrocyte membranes of patients with coronary atherosclerosis in various forms of dyslipoproteinemia].
Torkhovskaia TI; Khodzhakuliev BG; Khalilov EM; Kasatkina LV; Polesskiĭ VA
Vopr Med Khim; 1983; 29(5):69-73. PubMed ID: 6316664
[TBL] [Abstract][Full Text] [Related]
17. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
Goubran F; Maklady F; Saad M; el-Ashry M
Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
[TBL] [Abstract][Full Text] [Related]
18. [Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes].
Sinzinger H; Silberbauer K; Fitscha P; Kaliman J
Acta Med Austriaca; 1982; 9(5-6):181-4. PubMed ID: 7164754
[TBL] [Abstract][Full Text] [Related]
19. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.
Madej A; Okopien B; Kowalski J; Zielinski M; Wysocki J; Szygula B; Kalina Z; Herman ZS
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):345-9. PubMed ID: 9660044
[TBL] [Abstract][Full Text] [Related]
20. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)].
Drouin P; Méjean L; Lambert D; Wülfert E; Debry G
Nouv Presse Med; 1980 Dec; 9(49):3753-7. PubMed ID: 7208342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
